EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Nova Organic PCL (NV) fair value: what the stock is really worth

As of Oct 12, 2026: fair value of Nova Organic PCL THB 0.85, price THB 0.76, upside +11.8%, quality 53 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Consumer Defensive · TH

NO Thin data Oct 3, 2026

Nova Organic PCL

NV · BK

UndervaluedThe stock appears undervalued with acceptable quality.

Fair value 0.8500 THB · Undervalued (+11.8%)
Low debt
Quality 53/100
Mixed vs. peers (4/9)
Insider activity 45/100
Weak Growth (revenue 5y −23.2 %/yr in THB)
Loss-making · -5.8% net margin (TTM)
Negative free cash flow
Narrow moat 13/100 · thin data
Thin data

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

7.09 THB 0.4900 THB Fair Value 0.8500 THB Dec 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.

How to read this chart

58‑month range 0.4900 THB – 7.09 THB · fair‑value band 0.5600 THB – 1.06 THB · the 0.7600 THB price screens below the 0.8500 THB fair value. Dashed = 300-day average. As of Oct 3, 2026.

Follow Nova Organic PCL in your weekly email

Every Wednesday you see whether Nova Organic PCL is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nova Organic Public Company Limited engages in the production and distribution of food supplements and health beverages in Thailand.

Show more

Nova Organic Public Company Limited engages in the production and distribution of food supplements and health beverages in Thailand. It offers nutritional supplement products for health and beauty under the Donutt brand; nutritional supplement products for holistic health care under the LIVNEST brand; nutritional supplements and other products under Lingzhi Plus Shitake, Matsutake, and Chompoo24 brands, as well as Q-Tine, a hair product. The Company is also involved in the contract manufacturing business. The company was founded in 2012 and is based in Phra Samut Chedi, Thailand.

Stock analysis

Nova Organic PCL (NV) currently trades at 0.7600 THB, while our model-based Fair Value estimate is 0.8500 THB, implying the stock looks roughly 10.6% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.

Scenario range: 0.5600 THB (bear) to 1.06 THB (bull), the price of 0.7600 THB sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Consumer Defensive sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Nova Organic PCL reported revenue of 594M THB in FY2025 versus 1.2B THB in FY2021, a compound −16.7%/yr. Reported net income was −44.7M THB in FY2025.

Key figures

Market cap 438M THB (≈ $13.1M) · P/S ratio 0.54 · EPS (TTM) −0.0800 THB · Net margin −7.5% · Return on equity −4.0% · Return on assets (EBIT) −3.3% · Operating margin −14.2% · Revenue (TTM) 760M THB.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 4% below its 52-week high and 55% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 6% fair-value upside, at 12%, NV screens cheaper than that median.

Fair Value models

Bear 0.5600 THB Fair Value 0.8500 THB Bull 1.06 THB
Price 0.7600 THB · Upside +11.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 0.9500 THB 1.28 THB 1.91 THB 54
All 1 models by family
Asset-Based
NCAV (Graham) 0.9500 THB 1.28 THB 1.91 THB 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 53/100

Of which business quality 53 · Market factors (momentum, volatility) 52

Profitability 17
Margins and returns on capital today
Quality Growth 78
Are margins and returns improving?
Cashflow 5
Earnings quality: real cash, not paper profit
Fin. Strength 73
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 51
Calm price path (market factor)
Momentum 58
Price trend over the last 3–12 months (market factor)
52W Momentum 42
Distance to the 52-week high (market factor)
Net Issuance 85
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 6/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+3.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−23.2%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
44.2% (2020) → −8.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch NV, get fair value alerts →

Compare Nova Organic PCL with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 633 stocks

Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 53 · Below median
Fair Value upside +11.8% · Above median
Profitability
Return on assets −2.4% · Bottom 25%
Net margin (TTM) −5.8% · Bottom 25%
Operating margin (TTM) −14.2% · Bottom 25%
Growth and dividend
Revenue growth 54.5% · Top 25%
Balance sheet
Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/S (TTM) 0.02× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)49 · sector 35
FUTURE (revenue growth)100 · sector 23
PAST (return on equity)0 · sector 31
HEALTH (low debt)100 · sector 96
DIVIDEND (yield)0 · sector 58

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Inner Mongolia Yili Industrial Group 600887 ¥26.90 ¥41.84 +56% vs NV
Wilmar International Limited F34 3.68 SGD 5.14 SGD +40% vs NV
The Kraft Heinz Company KHC $22.19 $29.20 +32% vs NV
Foshan Haitian Flavouring and Food Company 603288 ¥33.93 ¥37.32 +10% vs NV
General Mills, Inc GIS $32.59 $34.59 +6% vs NV
Danone S.A BN €59.28 €50.65 −15% vs NV
Nestlé S.A NESN CHF 75.20 CHF 59.51 −21% vs NV
Kerry Group KRZ €85.55 €59.96 −30% vs NV
Nestlé India Limited NESTLEIND ₹1,363 ₹724.74 −47% vs NV
Yihai Kerry Arawana Holdings 300999 ¥24.55 ¥9.98 −59% vs NV

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Nova Organic PCL Fair Value". https://www.fairvalue-calculator.com/stock/NV

Frequently asked questions

Is Nova Organic PCL (NV) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 0.8500 THB versus a price of 0.7600 THB, about +12% upside (undervalued).
What is the fair value of NV?
Our model-based fair value for Nova Organic PCL is 0.8500 THB (as of Oct 3, 2026), built from audited fundamentals. The current price: 0.7600 THB.
What is the quality score of NV?
Nova Organic PCL has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nova Organic PCL (NV)?
Our model-based price target is the fair value of 0.8500 THB (as of Oct 3, 2026) from 1 valuation models. Cautious scenario 0.5600 THB, optimistic scenario 1.06 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the Nova Organic PCL stock forecast for 2026?
Our models put fair value at 0.8500 THB, about +12% upside versus a price of 0.7600 THB (undervalued). Cautious scenario 0.5600 THB, optimistic scenario 1.06 THB. The calculation is refreshed regularly with new filings.
What is the revenue of Nova Organic PCL (NV)?
Nova Organic PCL reported trailing-twelve-month revenue of about 760M THB (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of Nova Organic PCL (NV)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nova Organic PCL it is 0.8500 THB per share (as of Oct 3, 2026), against a price of 0.7600 THB. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Nova Organic PCL stock overvalued or undervalued in 2026?
As of Oct 3, 2026, NV trades below its calculated fair value: price 0.7600 THB, fair value 0.8500 THB, a gap of about +12% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NV?
No. The price is what the market pays today (0.7600 THB); the fair value is what the company's own numbers justify (0.8500 THB). For Nova Organic PCL the two are 0.0900 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is Nova Organic PCL worth?
The market values Nova Organic PCL at about 438M THB (market capitalisation, as of Oct 3, 2026). Per share that is 0.7600 THB; our models calculate a fair value of 0.8500 THB per share.
What do the bullish and bearish scenarios say about NV?
Our models span a range for Nova Organic PCL: cautious scenario 0.5600 THB, base 0.8500 THB, optimistic 1.06 THB per share (as of Oct 3, 2026, price 0.7600 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nova Organic PCL (NV)?
Balance-sheet figures for Nova Organic PCL (as of Oct 3, 2026): return on equity −4.0%, debt of 0.00 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is NV from its 52-week high?
Nova Organic PCL trades at 0.7600 THB, about 4% below its 52-week high of 0.7900 THB and 55% above the low of 0.4900 THB (as of Oct 12, 2026). Distance from the high says nothing about value: that is what the fair value of 0.8500 THB is for.
Which stocks are comparable to Nova Organic PCL?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nova Organic PCL stock attractive at the current price?
The data as of Oct 3, 2026: price 0.7600 THB, calculated fair value 0.8500 THB (+12%), Quality Score 53/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NV calculated?
We run Nova Organic PCL through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.8500 THB, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Nova Organic PCL currently trades 11 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nova Organic PCL (NV)?
The closing price on Oct 12, 2026 was 0.7600 THB. Our model-based fair value is 0.8500 THB, about +12% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nova Organic PCL right now?
A fairly wide model range (0.5600 THB to 1.06 THB) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Nova Organic PCL

How large is the market capitalisation of Nova Organic PCL (NV)?
The market capitalisation of Nova Organic PCL is 438M THB (≈ $13.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nova Organic PCL (NV)?
The price-to-sales ratio of Nova Organic PCL is 0.54 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nova Organic PCL (NV)?
Earnings per share at Nova Organic PCL are −0.0800 THB. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Nova Organic PCL (NV)?
The net margin of Nova Organic PCL is −7.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nova Organic PCL (NV)?
The return on equity (ROE) of Nova Organic PCL is −4.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nova Organic PCL (NV)?
On an EBIT basis the return on assets of Nova Organic PCL is −3.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nova Organic PCL (NV)?
The operating margin of Nova Organic PCL is −14.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nova Organic PCL (NV)?
Revenue at Nova Organic PCL is growing +54.5% versus a year earlier (3y avg −7.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Nova Organic PCL (NV)?
Earnings per share at Nova Organic PCL are growing −98.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Nova Organic PCL (NV) generate?
The free cash flow of Nova Organic PCL is −18.8M THB (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Nova Organic PCL (NV) hold?
Nova Organic PCL holds more cash than debt, 15.3M THB net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Nova Organic PCL in the live analysis

One click puts Nova Organic PCL on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.